- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
21 Cards in this Set
- Front
- Back
|
Rheumatoid Arthritis:
Clinical Features |
Systemic inflammatory dz
Symmetrical, erosive, polyarthritis (multiple joints involved; inflammn can cause damage to bone) |
|
Criteria for classification of RA
|
Based on joint involvement (small joints get more points), serology, duration
Need a score of at least 6 to achieve dx |
|
Extraarticular manifestations of RA
|
Rheumatoid nodules
Normocytic normochromic anemia Interstitial lung dz Pleuritiz/pericarditis |
|
Sjögren's Syndrome:
What is it? Risks? |
Chronic autoimmune rheumatic and lymphoproliferative dz characterized by dry eyes, dry mouth, resulting from immunologically mediated destruction of lacrimal and salivary glands
Inc'd risk of B cell lymphoma |
|
What antibodies are associated with Sjögren's Syndrome?
|
RF
ANA Ro/SS-A or La/SS-B |
|
HLA DR-4
|
Associated with RA in caucasians
|
|
Sjögren's Syndrome:
Presentation |
Pulmonary--dry trachea, bronchitis, interstitial pneumonitis, pseudolymphoma, lymphoma
B Cell Lymphoma GI: autoimmune liver dz, esophageal dysmotility, pancreatitis |
|
Type A vs Type B Synoviocytes
|
Type A: phagocytes
Type B: fibroblast-like (produce mediators for joint) |
|
What is a rheumatoid pannus?
|
Hypertrophied synovium (8-10 cells thick) heavily infiltrated with inflammatory cells
Invades and erodes bone and cartilage |
|
What defines a rheumatoid factor?
|
Any Ab that binds Fc portion of IgG molecule
|
|
CCP Antibodies
Effect of smoking |
Antibodies to Cyclic Citrullinated Peptides (CCP)
Highly specific for RA May be present early in dz; may be assocd w/dz severity Shared epitope (CCP-positive) + Smoking = 35x greater risk of developing RA |
|
What are the 5 stages of RA?
|
Stage I :presentation of unknown Ag to T cell by APC; no syx
Stage II: Initiation of inflammatory repsonse; T/B cell prolifertn Stage III: Nphils infiltrate synovial fluid; joint pain, swelling, morning stiffness Stage IV: Syx = those in stage III; radiographs show periarticular osteopenia Stage V: Erosion of subchondral bone, pannus invasion; x-rays show erosion and joint space narrowin |
|
These T cells are involved in RA.
|
Th1
|
|
These T cells are involved in SLE.
|
Th2
|
|
These cytokines are involved in the progression of RA.
How? |
TNF-alpha, IL-1
Macs: inc'd inflammn Endothelium: inc'd cell infiltration (via inc'd adhesion molecules), inc'd angiogenesis (via inc'd VEGF) Inc'd CRP in serum Inc'd articular cartilage degradation (metalloproteinase synthesis) |
|
What are the effects of IL-6?
|
B cell maturation, enhanced bone resorption, hepatocyte stimulus (dec'd albumin synthesis)
|
|
How can cytokines in RA be inhibited (via medication)?
|
-Inject soluble receptors that bind Ab's in bloodstream (means they're not allowed to bind cytokine receptors on cells), ex: TNG-alpha
-Receptor antagonists -Flood bloodstream with anti-inflammatory cytokines |
|
CTLA4Ig:
MOA |
Prevents second-signal req'd to activate Naive T Cells
remember: need 2 receptor signals to activate T cells |
|
IL-1Ra:
MOA |
IL-1 receptor antagonist
|
|
Rituximab:
MOA |
Anti-CD20
|
|
Tocilizumab:
MOA |
Anti-IL-6
|